We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-11.87%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$221B
AUM Growth
-$31.8B
Cap. Flow
+$2.77B
Cap. Flow %
1.26%
Top 10 Hldgs %
15.08%
Holding
8,767
New
731
Increased
3,710
Reduced
3,260
Closed
648

Sector Composition

Rank Sector Weight
1 Technology 8.03%
2 Financials 6.64%
3 Healthcare 6.26%
4 Consumer Discretionary 5.11%
5 Industrials 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFEQ icon
7251
VanEck Long/Flat Trend ETF
LFEQ
$28.3M
$9K ﹤0.01%
+385
New +$10.1K
OCGN icon
7252
Ocugen
OCGN
$416M
$9K ﹤0.01%
1,699
+1,674
+6,696% +$53.3K
ORMP icon
7253
Oramed Pharmaceuticals
ORMP
$167M
$9K ﹤0.01%
2,797
-396
-12% -$1.64K
PLXS icon
7254
Plexus
PLXS
$6.72B
$9K ﹤0.01%
185
-17,646
-99% -$994K
SACH
7255
Sachem Capital Corp
SACH
$39.1M
$9K ﹤0.01%
2,313
+360
+18% +$1.48K
SNGX icon
7256
Soligenix
SNGX
$5.54M
$9K ﹤0.01%
42
+41
+4,100% +$11.6K
SUPV
7257
Grupo Supervielle
SUPV
$828M
$9K ﹤0.01%
1,113
+962
+637% +$7.82K
TBT icon
7258
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
$9K ﹤0.01%
261
-53,478
-100% -$2.09M
VANI icon
7259
Vivani Medical
VANI
$110M
$9K ﹤0.01%
428
+396
+1,238% +$12.6K
VBND icon
7260
Vident US Bond Strategy ETF
VBND
$523M
$9K ﹤0.01%
198
-1,000
-83% -$47.2K
WHLRP
7261
Wheeler Real Estate Investment Trust Preferred Stock
WHLRP
$9.12M
$9K ﹤0.01%
1,166
-441
-27% -$7.12K
WSFS icon
7262
WSFS Financial
WSFS
$4.12B
$9K ﹤0.01%
247
-482
-66% -$20.3K
JCTC
7263
Jewett-Cameron Trading
JCTC
$9.33M
$9K ﹤0.01%
+1,334
New +$11.2K
RVNC
7264
DELISTED
Revance Therapeutics, Inc.
RVNC
$9K ﹤0.01%
448
-1,617
-78% -$35.6K
MIXT
7265
DELISTED
MIX TELEMATICS LIMITED
MIXT
$9K ﹤0.01%
551
+151
+38% +$2.41K
CURO
7266
DELISTED
CURO Group Holdings Corp.
CURO
$9K ﹤0.01%
1,000
-10,003
-91% -$164K
NM
7267
DELISTED
Navios Maritime Holdings Inc.
NM
$9K ﹤0.01%
3,207
-2,583
-45% -$11.5K
INFI
7268
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$9K ﹤0.01%
7,538
+522
+7% +$939
SURF
7269
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$9K ﹤0.01%
2,043
-6,352
-76% -$49.1K
TDW.WS.B
7270
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
$9K ﹤0.01%
5,751
+2,259
+65% +$6.71K
PSMG
7271
DELISTED
Invesco Growth Multi-Asset Allocation ETF
PSMG
$9K ﹤0.01%
+712
New +$9.6K
RBCN
7272
DELISTED
Rubicon Technology, Inc.
RBCN
$9K ﹤0.01%
1,163
+973
+512% +$7.91K
IDIV
7273
DELISTED
U.S. Equity Cumulative Dividends Fund - Series 2027
IDIV
$9K ﹤0.01%
+814
New +$10.2K
NDRAW
7274
DELISTED
ENDRA Life Sciences Inc. Warrants
NDRAW
$9K ﹤0.01%
17,150
+16,450
+2,350% +$16.4K
XDIV
7275
DELISTED
U.S. Equity Ex-Dividends Fund - Series 2027
XDIV
$9K ﹤0.01%
185

Similar funds

UBS Group's Q4 2018 Portfolio in Review

As of Q4 2018, UBS Group held 8,767 positions worth $221B, down 13% from $252B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group's Q4 2018 filing shows 731 new, 3,710 increased, 3,260 reduced and 648 closed positions. Its largest new stake was Linde: 4,971,408 shares worth $776M. The largest sale was Energy Transfer Partners, L.P., an estimated $1.06B.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9.3% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2018 buy was Linde: 4,971,408 shares worth $776M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.82B increase.
  • UBS Group's biggest Q4 2018 reduction was Colgate-Palmolive, cutting an estimated $665M.
  • UBS Group fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.06B.
  • UBS Group's ten largest holdings make up 15% of its $221B portfolio in Q4 2018.
  • UBS Group opened 731 new positions and closed 648 in Q4 2018.
  • UBS Group's portfolio value fell 13% quarter-over-quarter to $221B.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.